A Phase I Study of BKM120 in Adult Chinese Patients With Advanced Solid Tumors

Clinical trial NCT01626209 · COMPLETED

Trial details

NCT number: NCT01626209
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Breast Cancer, Advanced Carcinomas With Squamous Cell Histology

Start date: 2012-07-01
Primary completion: 2014-04-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.